317 related articles for article (PubMed ID: 17870166)
1. The classical complement pathway plays a critical role in the opsonisation of uropathogenic Escherichia coli.
Li K; Sacks SH; Sheerin NS
Mol Immunol; 2008 Feb; 45(4):954-62. PubMed ID: 17870166
[TBL] [Abstract][Full Text] [Related]
2. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
[TBL] [Abstract][Full Text] [Related]
3. Synergy between type 1 fimbriae expression and C3 opsonisation increases internalisation of E. coli by human tubular epithelial cells.
Li K; Zhou W; Hong Y; Sacks SH; Sheerin NS
BMC Microbiol; 2009 Mar; 9():64. PubMed ID: 19335887
[TBL] [Abstract][Full Text] [Related]
4. Complement-independent adherence of Escherichia coli to complement receptors in vitro.
Fine DP; Harper BL; Carpenter ED; Davis CP; Cavallo T; Guckian JC
J Clin Invest; 1980 Sep; 66(3):465-72. PubMed ID: 6105165
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin-independent utilization of the classical complement pathway in opsonophagocytosis of Escherichia coli by human peripheral leukocytes.
Leist-Welsh P; Bjornson AB
J Immunol; 1982 Jun; 128(6):2643-51. PubMed ID: 6210733
[No Abstract] [Full Text] [Related]
6. Activation of the classical pathway of complement by binding of bovine lactoferrin to unencapsulated Streptococcus agalactiae.
Rainard P
Immunology; 1993 Aug; 79(4):648-52. PubMed ID: 8406591
[TBL] [Abstract][Full Text] [Related]
7. [The role of the complement system in the defence against infections and new ways of assessing the activation routes].
Seelen MA; Trouw LA; Daha A; Roos A
Ned Tijdschr Geneeskd; 2004 Nov; 148(47):2318-23. PubMed ID: 15587049
[TBL] [Abstract][Full Text] [Related]
8. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.
Billips BK; Yaggie RE; Cashy JP; Schaeffer AJ; Klumpp DJ
J Infect Dis; 2009 Jul; 200(2):263-72. PubMed ID: 19522648
[TBL] [Abstract][Full Text] [Related]
9. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
Nielsen EW; Waage C; Fure H; Brekke OL; Sfyroera G; Lambris JD; Mollnes TE
Mol Immunol; 2007 Mar; 44(8):1819-26. PubMed ID: 17101176
[TBL] [Abstract][Full Text] [Related]
10. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
[TBL] [Abstract][Full Text] [Related]
11. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice.
Brown JS; Hussell T; Gilliland SM; Holden DW; Paton JC; Ehrenstein MR; Walport MJ; Botto M
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16969-74. PubMed ID: 12477926
[TBL] [Abstract][Full Text] [Related]
12. Current concepts of molecular defence mechanisms operative during urinary tract infection.
Weichhart T; Haidinger M; Hörl WH; Säemann MD
Eur J Clin Invest; 2008 Oct; 38 Suppl 2():29-38. PubMed ID: 18826479
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum.
Walpen AJ; Laumonier T; Aebi C; Mohacsi PJ; Rieben R
Xenotransplantation; 2004 Mar; 11(2):141-8. PubMed ID: 14962276
[TBL] [Abstract][Full Text] [Related]
14. Uropathogenic Escherichia coli as a model of host-parasite interaction.
Svanborg C; Bergsten G; Fischer H; Godaly G; Gustafsson M; Karpman D; Lundstedt AC; Ragnarsdottir B; Svensson M; Wullt B
Curr Opin Microbiol; 2006 Feb; 9(1):33-9. PubMed ID: 16406777
[TBL] [Abstract][Full Text] [Related]
15. Impact of Toll-like receptor signalling on urinary tract infection.
Scherberich JE; Hartinger A
Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S9-14. PubMed ID: 17942281
[TBL] [Abstract][Full Text] [Related]
16. CD46 (membrane cofactor protein) acts as a human epithelial cell receptor for internalization of opsonized uropathogenic Escherichia coli.
Li K; Feito MJ; Sacks SH; Sheerin NS
J Immunol; 2006 Aug; 177(4):2543-51. PubMed ID: 16888016
[TBL] [Abstract][Full Text] [Related]
17. Anti-capsular antibodies activate killing of Escherichia coli O8:K87 by the alternate complement pathway in porcine serum.
Clark NM; Berberov EM; Wang M; Moxley RA
Vet Immunol Immunopathol; 2006 Nov; 114(1-2):185-91. PubMed ID: 16919781
[TBL] [Abstract][Full Text] [Related]
18. Complement-mediated immune mechanisms in renal infection. II. Effect of decomplementation.
Miller TE; Phillips S; Simpson IJ
Clin Exp Immunol; 1978 Jul; 33(1):115-21. PubMed ID: 361314
[TBL] [Abstract][Full Text] [Related]
19. [A mechanism of human complement activation by immunostimulators from the bacterial cell wall].
Kozlov LV; Zinchenko AA; Soliakov LS; Sizoĭ MN; Ishchenko AM
Bioorg Khim; 1983 Aug; 9(8):1047-55. PubMed ID: 6680304
[TBL] [Abstract][Full Text] [Related]
20. Interaction of uropathogenic Escherichia coli with host uroepithelium.
Kau AL; Hunstad DA; Hultgren SJ
Curr Opin Microbiol; 2005 Feb; 8(1):54-9. PubMed ID: 15694857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
